SightfileU.S. market data from official filings

Companies › VSEE

VSee Health Inc (VSEE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001864531 · EDGAR filings · Updated 2026-07-24

VSee Health Inc (VSEE) has reported institutional ownership of 6.4%, with 13 institutional managers holding positions valued at $1.11M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings, triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04).

Institutional ownership
6.4%
Institutional managers
13
Reported 13F value
$1.11M
Insider activity
51 trans.
$0 net flat
Data flags
4 active
from SEC filings

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VSee Health Inc has 13 institutional holders and institutional ownership of 6.4%.

Insider activity

Insiders reported 51 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active triggering event that accelerates or increases a direct financial obligation (8-K Item 2.04), most recently filed 2026-06-26 (recurring since 2026-06-26) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2022-03-29) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-09-29 (recurring since 2023-04-06) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2025-08-28 (recurring since 2025-08-28) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Lexaria Bioscience Corp (LEXX) · IGC PHARMA INC (IGC) · Alterity Therapeutics Ltd (ATHE) · Mannatech Inc (MTEX) · CHARMING MEDICAL LTD (MCTA) · ALLARITY THERAPEUTICS INC (ALLR)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.